Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease

被引:101
作者
Brück, A [1 ]
Aalto, S [1 ]
Nurmi, E [1 ]
Bergman, J [1 ]
Rinne, JO [1 ]
机构
[1] Univ Turku, Turku PET Ctr, FIN-20521 Turku, Finland
关键词
Parkinson's disease; PET; 6-[F-18]fluoro-L-dopa; frontal lobe functions; cognition; attention;
D O I
10.1016/j.neurobiolaging.2004.07.014
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
yPatients with Parkinson's disease (PD) have already at the early stages of the disease impaired performance especially in tests measuring frontal lobe functions such as attention. The pathophysiological basis of these deficits is unclear. In the present study, 21 non-demented, non-medicated patients at the early stage of PD and 24 healthy controls underwent a positron emission tomography (PET) scan with 6[F-18]fluoro-L-dopa (Fdopa) as the tracer. In addition, the PD patients performed a neuropsychological test battery, including a test measuring sustained attention (VIG) and a test requiring suppressed attention (Stroop). Both voxel-based Statistical Parametric Mapping (SPM) and automated region of interest (ROI) analysis were employed. Compared to controls, the PD patients had decreased Fdopa uptake in the striatum and a large cortical area of increased Fdopa uptake. The reaction time in the VIG test correlated positively with the Fdopa uptake of the dorsolateral prefrontal cortex and the performance in the Stroop test correlated negatively with the Fdopa uptake in an area including the medial frontal cortex and the anterior cingulate. The results show that cortical Fdopa uptake is increased in early non-medicated PD and suggest that the changes in frontal Fdopa uptake are related to cognitive impairments found in early PD. (c) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:891 / 898
页数:8
相关论文
共 53 条
[21]  
HORNYKIEWICZ O, 1979, ADV NEUROL, V24, P275
[22]   A CLINICOPATHOLOGICAL STUDY OF 100 CASES OF PARKINSONS-DISEASE [J].
HUGHES, AJ ;
DANIEL, SE ;
BLANKSON, S ;
LEES, AJ .
ARCHIVES OF NEUROLOGY, 1993, 50 (02) :140-148
[23]   Striatal and extrastriatal dysfunction in Parkinson's disease with dementia:: a 6-[18F]fluoro-L-dopa PET study [J].
Ito, K ;
Nagano-Saito, A ;
Kato, T ;
Arahata, Y ;
Nakamura, A ;
Kawasumi, Y ;
Hatano, K ;
Abe, Y ;
Yamada, T ;
Kachi, T ;
Brooks, DJ .
BRAIN, 2002, 125 :1358-1365
[24]   Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease [J].
Ito, K ;
Morrish, PK ;
Rakshi, JS ;
Uema, T ;
Ashburner, J ;
Bailey, DL ;
Friston, KJ ;
Brooks, DJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (06) :754-758
[25]   DISTRIBUTION OF MONOAMINERGIC, CHOLINERGIC, AND GABAERGIC MARKERS IN THE HUMAN CEREBRAL-CORTEX [J].
JAVOYAGID, F ;
SCATTON, B ;
RUBERG, M ;
LHEUREUX, R ;
CERVERA, P ;
RAISMAN, R ;
MALOTEAUX, JM ;
BECK, H ;
AGID, Y .
NEUROSCIENCE, 1989, 29 (02) :251-259
[26]   Increased frontal [18F]fluorodopa uptake in early Parkinson's Disease:: sex differences in the prefrontal cortex [J].
Kaasinen, V ;
Nurmi, E ;
Brück, A ;
Bergman, J ;
Solin, O ;
Rinne, JO .
BRAIN, 2001, 124 :1125-1130
[27]   Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease [J].
Kaasinen, V ;
Någren, K ;
Hietala, J ;
Oikonen, V ;
Vilkman, H ;
Farde, L ;
Halldin, C ;
Rinne, JO .
NEUROLOGY, 2000, 54 (07) :1482-1487
[28]   Positron emission tomography of striatal serotonin transporters in Parkinson disease [J].
Kerenyi, L ;
Ricaurte, GA ;
Schretlen, DJ ;
McCann, U ;
Varga, J ;
Mathews, WB ;
Ravert, HT ;
Dannals, RF ;
Hilton, J ;
Wong, DF ;
Szabo, Z .
ARCHIVES OF NEUROLOGY, 2003, 60 (09) :1223-1229
[29]   ATTENTION RELATED PERFORMANCE IN 2 COGNITIVELY DIFFERENT SUBGROUPS OF PATIENTS WITH MULTIPLE-SCLEROSIS [J].
KUJALA, P ;
PORTIN, R ;
REVONSUO, A ;
RUUTIAINEN, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 59 (01) :77-82